{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:08:10Z","timestamp":1770347290727,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11940-008-0017-x","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T14:15:30Z","timestamp":1210860930000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Central nervous system histoplasmosis"],"prefix":"10.1007","volume":"10","author":[{"given":"Michael","family":"Saccente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,16]]},"reference":[{"issue":"Suppl2","key":"17_CR1","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/clinids\/22.Supplement_2.S102","volume":"22","author":"R.W. Bradsher","year":"1996","unstructured":"Bradsher RW: Histoplasmosis and blastomycosis. Clin Infect Dis 1996, 22(Suppl 2):S102\u2013S111.","journal-title":"Clin Infect Dis"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/iai.55.6.1355-1358.1987","volume":"55","author":"G. Medoff","year":"1987","unstructured":"Medoff G, Kobayashi GS, Painter A, Travis S: Morphogenesis and pathogenicity of\n                           Histoplasma capsulatum. Infect Immun 1987, 55:1355\u20131358.","journal-title":"Infect Immun"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199011000-00004","volume":"69","author":"L.J. Wheat","year":"1990","unstructured":"Wheat LJ, Connolly-Stringfield PA, Baker RL, et al.: Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990, 69:361\u2013374.","journal-title":"Medicine (Baltimore)"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0002-9343(88)90416-0","volume":"84","author":"E. Anaissie","year":"1988","unstructured":"Anaissie E, Fainstein V, Samo T, et al.: Central nervous system histoplasmosis: an unappreciated complication of the acquired immunodeficiency syndrome. Am J Med 1988, 84:215\u2013217.","journal-title":"Am J Med"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00005792-199007000-00006","volume":"69","author":"L.J. Wheat","year":"1990","unstructured":"Wheat LJ, Batteiger BE, Sathapatayavongs B: Histoplasma capsulatum\n                           infections of the central nervous system: a clinical review. Medicine (Baltimore) 1990, 69:244\u2013260.","journal-title":"Medicine (Baltimore)"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/art.10583","volume":"46","author":"J.-H. Lee","year":"2002","unstructured":"Lee J-H, Slifman NR, Gershon SK, et al.: Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor \u03b1 antagonists infliximab and etanercept. Arthritis Rheum 2002, 46:2565\u20132570.","journal-title":"Arthritis Rheum"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00005792-199709000-00002","volume":"76","author":"L.J. Wheat","year":"1997","unstructured":"Wheat LJ: Histoplasmosis: experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 1997, 76:339\u2013354.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl1","key":"17_CR8","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/clinids\/14.Supplement_1.S60","volume":"14","author":"G.A. Sarosi","year":"1992","unstructured":"Sarosi GA, Johnson PC: Disseminated histoplasmosis in patients with human immunodeficiency virus. Clin Infect Dis 1992, 14(Suppl 1):S60\u2013S67.","journal-title":"Clin Infect Dis"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0002-9343(85)90427-9","volume":"78","author":"L.J. Wheat","year":"1985","unstructured":"Wheat LJ, Slama TG, Zeckel ML: Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 1985, 78:203\u2013210.","journal-title":"Am J Med"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1086\/427880","volume":"40","author":"L.J. Wheat","year":"2005","unstructured":"Wheat LJ, Musial CE, Jenny-Avital E: Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005, 40:844\u2013852.","journal-title":"Clin Infect Dis"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM198601093140205","volume":"314","author":"L.J. Wheat","year":"1986","unstructured":"Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of\n                           Histoplasma capsulatum\n                           antigen in serum and urine specimens. N Engl J Med 1986, 314:83\u201388.","journal-title":"N Engl J Med"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","volume":"45","author":"L.J. Wheat","year":"2007","unstructured":"Wheat LJ, Freifeld AG, Kleiman MB, et al.: Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007, 45:807\u2013825.","journal-title":"Clin Infect Dis"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/0003-4819-118-8-199304150-00006","volume":"118","author":"J. Wheat","year":"1993","unstructured":"Wheat J, Hafner R, Wulfsohn M, et al.: Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993, 118:610\u2013616.","journal-title":"Ann Intern Med"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1086\/420749","volume":"38","author":"M. Goldman","year":"2004","unstructured":"Goldman M, Zackin R, Fichtenbaum CJ, et al.: Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004, 38:1485\u20131489.","journal-title":"Clin Infect Dis"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","volume":"137","author":"P.C. Johnson","year":"2002","unstructured":"Johnson PC, Wheat LJ, Cloud GA, et al.: Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002, 137:105\u2013109.","journal-title":"Ann Intern Med"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1086\/315643","volume":"182","author":"A.H. Groll","year":"2000","unstructured":"Groll AH, Giri N, Petraitis V, et al.: Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental\n                           Candida albicans\n                           infection of the central nervous system. J Infect Dis 2000, 182:274\u2013282.","journal-title":"J Infect Dis"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/01.SMJ.0000051734.53654.D0","volume":"96","author":"M. Saccente","year":"2003","unstructured":"Saccente M, McDonnell RW, Baddour LM, et al.: Cerebral histoplasmosis in the azole era: report of four cases and review. South Med J 2003, 96:410\u2013416.","journal-title":"South Med J"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1086\/313748","volume":"30","author":"W.E. Dismukes","year":"2000","unstructured":"Dismukes WE: Introduction to antifungal drugs. Clin Infect Dis 2000, 30:653\u2013657.","journal-title":"Clin Infect Dis"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/504492","volume":"43","author":"E.S.D. Ashley","year":"2006","unstructured":"Ashley ESD, Lewis R, Lewis JS, et al.: Pharmacology of systemic antifungal agents. Clin Infect Dis 2006, 43:S28\u2013S39.","journal-title":"Clin Infect Dis"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/archinte.148.11.2389","volume":"148","author":"R.A. Branch","year":"1988","unstructured":"Branch RA: Prevention of amphotericin B-induced renal impairment: a review on the use of sodium supplementation. Arch Intern Med 1988, 148:2389\u20132394.","journal-title":"Arch Intern Med"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/clinids\/20.4.755","volume":"20","author":"S.D. Goodwin","year":"1995","unstructured":"Goodwin SD, Cleary JD, Walawonder CA, et al.: Pretreatment regimens for adverse events related to infusion of amphotericin B. Clin Infect Dis 1995, 20:755\u2013761.","journal-title":"Clin Infect Dis"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0002-9343(99)80311-8","volume":"98","author":"J. Wheat","year":"1995","unstructured":"Wheat J, Hafner R, Korzun AH, et al.: Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 1995, 98:336\u2013342.","journal-title":"Am J Med"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0002-9343(97)00151-4","volume":"103","author":"J. Wheat","year":"1997","unstructured":"Wheat J, MaWhinney S, Hafner R, et al.: Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med 1997, 103:223\u2013232.","journal-title":"Am J Med"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1086\/340825","volume":"185","author":"R.R. Haynes","year":"2002","unstructured":"Haynes RR, Connolly PA, Durkin MM, et al.: Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection. J Infect Dis 2002, 185:1830\u20131832.","journal-title":"J Infect Dis"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1056\/NEJM199401273300407","volume":"330","author":"J.A. Como","year":"1994","unstructured":"Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994, 330:263\u2013271.","journal-title":"N Engl J Med"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJM200103293441307","volume":"344","author":"S.C. Piscitelli","year":"2001","unstructured":"Piscitelli SC, Gallicano KD: Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001, 344:984\u2013996.","journal-title":"N Engl J Med"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/00006454-199912000-00007","volume":"18","author":"C.M. Odio","year":"1999","unstructured":"Odio CM, Navarrete M, Carrillo JM, et al.: Disseminated histoplasmosis in infants. Pediatr Infect Dis 1999, 18:1065\u20131068.","journal-title":"Pediatr Infect Dis"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-008-0017-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0017-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:55:41Z","timestamp":1659095741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-008-0017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s11940-008-0017-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"16 May 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}